perfluorooctane has been researched along with Age-Related Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikuno, Y; Kamei, M; Maeno, T; Mitsuda, H; Tano, Y; Yuasa, T | 1 |
| Khan, MM; Lambert, HM; Lomeo, MD; LoRusso, FJ; Merrill, PT; Saxe, SJ | 1 |
2 other study(ies) available for perfluorooctane and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid.
Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Macula Lutea; Macular Degeneration; Male; Middle Aged; Plasminogen Activators; Recurrence; Retinal Hemorrhage; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy | 1996 |
Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Fovea Centralis; Humans; Intraoperative Complications; Macular Degeneration; Male; Middle Aged; Recurrence; Retrospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 1999 |